Fig. 2: Dynamic changes of the cytogenetic burden in adults with KMT2Ar AML following treatment.
From: Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements
Numbers depict the estimated % of KMT2Ar measured by fluorescence in situ hybridization (FISH) or conventional cytogenetics when FISH was not performed. Numbers below the X-axis indicate the proportion (%) of patients with KMT2Ar among those with available cytogenetic data. This analysis included unique patients from the newly diagnosed cohort in addition to patients who presented to our institution with relapsed or refractory disease. The long-term remission graph depicts those who achieved and maintained a morphologic remission whereas the relapse graph depicts those with initial morphologic remission following induction treatment and subsequent relapse.
